查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941472

自动注射器市场规模、份额和趋势分析报告：按产品、适应症、最终用途、地区和细分市场预测，2026-2033年

Autoinjectors Market Size, Share, & Trends Analysis By Product, By Indication, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10个工作天内

价格

自动注射器市场概况

2025年全球自动注射器市场规模估计为102亿美元，预计2033年将达到284亿美元。

预计从 2026 年到 2033 年，自动注射器市场将以 13.8% 的复合年增长率成长。自动注射器市场的主要驱动力是糖尿病和过敏性休克等慢性疾病的增加，这些疾病催生了对易于使用的药物传输系统的需求。

人们对自我给药益处的认识不断提高，生物製药的进步以及技术创新，都提升了安全性和易用性。政府的支持性政策、不断增长的医疗保健支出以及对微创设备的需求，进一步推动了市场成长。

由于其高效先进的给药能力以及与新型药物製剂的兼容性，自动注射器比传统注射器更受欢迎。其诸多优势，包括减轻针头恐惧症和焦虑、降低针刺伤风险、剂量精准稳定以及疗效提升，正推动着不同患者群体对自动注射器的广泛应用。同样，易于使用的家用自动注射器日益普及和便利性的便利性也进一步促进了其应用。例如，2024年5月，美国食品药物管理局（FDA）核准了贝利尤单抗（Benlysta）自动注射器用于5岁及以上患有狼疮的儿童的居家治疗。此项核准旨在提高治疗的可近性和便利性，使看护者能够在医疗机构之外为患者用药。自动注射器的设计旨在提高患者的治疗依从性，这对于有效控制狼疮至关重要。

此外，类风湿性关节炎、多发性硬化症和过敏性休克等需要频繁注射的疾病，由于其易用性、准确性和患者依从性，已成为自动注射器的首选。生物製药和生物相似药的普及，尤其是在免疫学和肿瘤学等治疗领域，进一步推动了市场需求。生物製药公司正积极投资以患者为中心的给药技术，并致力于使自动注射器与更广泛的製剂相容。此外，家庭治疗方案的增加和患者对自我给药偏好的提高，也进一步推动了这些设备的普及，在改善患者疗效的同时，减轻了医疗机构的负担。

目录

第一章调查方法和范围

第二章执行摘要

第三章 自动注射器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 自动注射器市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 自动注射器市场：依产品分類的估算与趋势分析

  • 自动注射器市场：按产品分類的波动分析
  • 自动注射器市场：产品展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 一次性自动注射器
  • 可重复使用的自动注射器

第五章 自动注射器市场：依适应症分類的估算与趋势分析

  • 自动注射器市场：按适应症分類的波动分析
  • 自动注射器市场：按适应症分類的展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 类风湿性关节炎
  • 多发性硬化症
  • 糖尿病
  • 过敏反应
  • 其他的

第六章 自动注射器市场：依最终用途分類的估算与趋势分析

  • 自动注射器市场：按最终用途分類的差异分析
  • 自动注射器市场：按最终用途分類的展望
  • 市场规模、预测与趋势分析（2021-2033）
  • 居家医疗环境
  • 医院和诊所
  • 门诊手术中心

第七章 自动注射器市场：区域估算与趋势分析

  • 区域仪錶板
  • 自动注射器市场波动区域分析
  • 自动注射器市场：区域估算和趋势分析（按产品、适应症和最终用途划分）
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 市场参与企业分类
  • 2025年企业市场占有率分析
  • 主要企业简介
    • Eli Lilly
    • SHL Medical AG
    • AbbVie, Inc.
    • Amgen
    • Owen Mumford
    • Ypsomed
    • Teva Pharmaceutical
    • Biogen Idec
    • Mylan NV
    • Pfizer, Inc.
    • Sanofi
    • Gerresheimer AG
Product Code: GVR-3-68038-397-3

Autoinjectors Market Summary

The global autoinjectors market size was estimated at USD 10.2 billion in 2025 and is projected to reach USD 28.4 billion by 2033, growing at a CAGR of 13.8% from 2026 to 2033. The auto injectors market is driven by the increasing prevalence of chronic diseases such as diabetes and anaphylaxis, necessitating user-friendly medication delivery systems.

Rising awareness of self-administration benefits, advancements in biologics, and technological innovations enhance safety and ease of use. Supportive government policies, increased healthcare expenditure, and demand for minimally invasive devices further boost market growth.

Autoinjectors are preferred over conventional devices due to their efficient and enhanced drug delivery capabilities and compatibility with new formulations. They offer several benefits, including reduced needle phobia and anxiety, decreased risk of needle stick injuries, consistent dose accuracy, and improved efficacy, which drives their adoption in diverse patient pools. Similarly, the increasing availability and access to user friendly autoinjectors which can be administered at home is further increasing their adoption. For instance, in May 2024, the FDA approved the Benlysta autoinjector for at-home use in children aged 5 years and older with lupus. This approval aims to improve treatment accessibility and convenience, allowing caregivers to administer the medication outside of clinical settings. The autoinjector is designed to enhance patient adherence to therapy, which is crucial for managing lupus effectively.

Moreover, conditions such as rheumatoid arthritis, multiple sclerosis, and anaphylaxis require frequent injections, making auto-injectors a preferred option due to their ease of use, accuracy, and patient compliance benefits. The shift towards biologics and biosimilars, particularly in therapeutic areas such as immunology and oncology, is further fueling demand. Biopharmaceutical companies are actively investing in patient-centric drug delivery technologies, ensuring that auto-injectors are compatible with a broader range of formulations. In addition, the expansion of home-based treatment options and self-administration preferences has further strengthened the adoption of these devices, reducing the burden on healthcare facilities while improving patient outcomes.

Global Autoinjectors Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global autoinjectors market report on the basis of product, indication, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Disposable auto-injectors
  • Reusable auto-injectors
    • Prefilled
    • Empty
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Homecare Settings
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Product
    • 1.1.2. Indication
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Indication outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Autoinjectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of targeted therapies
      • 3.2.1.2. Increase in the incidence of anaphylactic shock
      • 3.2.1.3. Patients' preference to choose self-administration of injections
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of its substitute products like general injections and oral tablets
  • 3.3. Auto-Injectors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Autoinjectors Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Autoinjectors Market: Product Movement Analysis
  • 4.3. AutoinjectorsMarket by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 4.5. Disposable Auto-Injectors
    • 4.5.1. Disposable Autoinjectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Reusable Auto-Injectors
    • 4.6.1. Reusable Autoinjectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.1. Prefilled Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.6.1.1.1. Prefilled Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.1.2. Empty Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.6.1.2.1. Empty Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Autoinjectors Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Autoinjectors Market: Indication Movement Analysis
  • 5.3. AutoinjectorsMarket by Indication Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 5.5. Rheumatoid Arthritis
    • 5.5.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Multiple Sclerosis
    • 5.6.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Diabetes
    • 5.7.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Anaphylaxis
    • 5.8.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Other Therapies
    • 5.9.1. Other Therapies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Autoinjectors Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Autoinjectors Market: End Use Movement Analysis
  • 6.3. Autoinjectors Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 6.5. Homecare Settings
    • 6.5.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Hospitals & Clinics
    • 6.6.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ambulatory Surgical Centers
    • 6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Autoinjectors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Autoinjectors Market movement analysis
  • 7.3. Autoinjectors Market: Regional Estimates & Trend Analysis by Product, Indication & End Use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Autoinjectors Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share Analysis, 2025
  • 8.3. Key Company Profiles
    • 8.3.1. Eli Lilly
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. SHL Medical AG
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. AbbVie, Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Amgen
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Owen Mumford
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Ypsomed
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Teva Pharmaceutical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Biogen Idec
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Mylan N.V.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Pfizer, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Sanofi
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Gerresheimer AG
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 5 Global Autoinjectors market, by End Use (USD Million) 2021 - 2033
  • Table 6 North America Autoinjectors market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 9 North America Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 10 U.S. Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 12 U.S. Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 15 Canada Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 18 Mexico Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Autoinjectors market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 22 Europe Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 UK Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 25 UK Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 26 Germany Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 28 Germany Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 France Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 30 France Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 31 France Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 34 Italy Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 37 Spain Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 Norway Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 39 Norway Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 40 Norway Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden Autoinjectors , by indication, 2021 - 2033 (USD Million)
  • Table 43 Sweden Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Denmark Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 45 Denmark Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 46 Denmark Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Autoinjectors market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Japan Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 52 Japan Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 53 Japan Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 China Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 55 China Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 56 China Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 57 India Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 58 India Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 59 India Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 60 Australia Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 61 Australia Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 62 Australia Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 South Korea Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 64 South Korea Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 65 South Korea Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 68 Thailand Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Autoinjectors market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 72 Latin America Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 75 Brazil Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 78 Argentina Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa Autoinjectors market, by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 85 South Africa Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 91 UAE Autoinjectors market, by End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Autoinjectors market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Autoinjectors market, by indication, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Autoinjectors market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Auto-Injectors market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Auto-injectors market, type outlook key takeaways (USD Million)
  • Fig. 12 Auto-injectors market type movement analysis (USD Million), 2025 & 2033
  • Fig. 13 Disposable auto-injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Reusable auto-injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Prefilled market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Empty market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Auto-injectors market, indication outlook key takeaways (USD Million)
  • Fig. 18 Auto-injectors market indication movement analysis (USD Million), 2025 & 2033
  • Fig. 19 Rheumatoid arthritis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Multiple sclerosis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Anaphylaxis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Other therapies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Auto-injectors market, end use outlook key takeaways (USD Million)
  • Fig. 25 Auto-injectors market end use movement analysis (USD Million), 2025 & 2033
  • Fig. 26 Homecare settings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Auto-injectors market: Regional key takeaways (USD Million)
  • Fig. 30 Auto-injectors market regional outlook, 2025 & 2033, USD Million
  • Fig. 31 North America auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Canada auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Europe auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 UK auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Germany auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 France auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Spain auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Italy auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Sweden auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Norway auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Denmark auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Asia Pacific auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 China auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Japan auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 India auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 South Korea auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Australia auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Thailand auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Latin America auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Brazil auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Argentina auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Middle East and Africa auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 South Africa auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Saudi Arabia auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 UAE auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Kuwait auto-injectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 List of key emerging company's/indication disruptors/innovators